Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
about
Emerging role of sphingosine-1-phosphate signaling in head and neck squamous cell carcinomaProtein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signalingHigh level expression of AMAP1 protein correlates with poor prognosis and survival after surgery of head and neck squamous cell carcinoma patientsInhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.mTOR co-targeting in cetuximab resistance in head and neck cancers harboring PIK3CA and RAS mutations.YM155 induces EGFR suppression in pancreatic cancer cells.Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway.MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1.MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.Extracellular ATP stimulates epithelial cell motility through Pyk2-mediated activation of the EGF receptorPreparation and antitumor effect of a toxin-linked conjugate targeting vascular endothelial growth factor receptor and urokinase plasminogen activator.Treatment of recurrent metastatic head and neck cancer: focus on cetuximab.Immunotherapy for head and neck cancer patients: shifting the balance.Expanding the foundation for personalized medicine: implications and challenges for dentistry.Antitumor effects of EGFR antisense guanidine-based peptide nucleic acids in cancer models.TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.ANO1/TMEM16A interacts with EGFR and correlates with sensitivity to EGFR-targeting therapy in head and neck cancerPrevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.Regulation of EGFR protein stability by the HECT-type ubiquitin ligase SMURF2.Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors.Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes.Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process
P2860
Q26744051-2AB17C07-22F2-4B9B-8FAD-549FE6EDCD3DQ26861795-EE2165FC-1BDF-4005-9DEA-96D3DBD00B02Q28658539-F52847A9-902A-40D3-BE39-98A9E59BF85FQ34012333-31AABA1C-BBF7-40AF-AB88-9AEE22CFE580Q34049613-5A8AB09B-B4C4-4368-9BFA-BC67A439EEAFQ34313903-32F8B60B-AC80-4D6D-896E-10D9F408669DQ34393001-BFDC4021-58E4-4218-87F8-D41B9368F6DBQ34555750-73154CB4-B970-4462-B71E-484887A36A5BQ35037596-0CC81A90-0AA6-44CB-B2AD-E368AFAEC19AQ35250443-9CDA458A-18DF-4572-AE12-2F2F59855763Q37071261-5321E2D1-40E1-4202-811F-B61448F8F53CQ37218978-C3EEA7F2-2615-4469-9E03-B4A858DB9973Q38068966-658177FD-E5C0-45FC-BC76-80273E4EB46EQ38108276-260B864A-BF33-42FE-9F1B-FA159AF01B85Q38320343-A91E0B32-E235-41DB-904B-4D4BC4A72060Q38717360-636BF11F-CD75-4C29-BA58-2740851CA8F0Q38893078-6844E79B-BA4A-4CF1-BA96-49E0C4CB8A4CQ39073840-C469A4F2-D315-4EE4-9FAA-96BFB706BCE4Q39158710-BCD65D13-7FB6-452C-9C9C-0FCE0A3DC339Q39507845-78642F04-24C1-4BC6-8D8E-C01E091EFF2FQ47136456-3646758B-4F5A-4CE9-90C5-1D1E0B7CF9E8Q50203153-72DFD54A-804A-4F11-AE35-B4009A17F291Q58573146-E05F9886-AEE7-4D25-8DE0-6EEDB7835ED9
P2860
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@en
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@nl
type
label
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@en
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@nl
prefLabel
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@en
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@nl
P2860
P1476
Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.
@en
P2093
Andre Cassell
P2860
P304
P356
10.1517/13543781003769844
P407
P577
2010-06-01T00:00:00Z